SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yoshihide Ueda, Toshimi Kaido, Takashi Ito, Kohei Ogawa, Atsushi Yoshizawa, Yasuhiro Fujimoto, Akira Mori, Aya Miyagawa-Hayashino, Hironori Haga, Hiroyuki Marusawa, Tsutomu Chiba, Shinji Uemoto, Chronic Rejection Associated with Antiviral Therapy for Recurrent Hepatitis C after Living-Donor Liver Transplantation, Transplantation Journal, 2014, 97, 3, 344

    CrossRef

  2. 2
    E. J. Gane, K. Agarwal, Directly Acting Antivirals (DAAs) for the Treatment of Chronic Hepatitis C Virus Infection in Liver Transplant Patients: “A Flood of Opportunity”, American Journal of Transplantation, 2014, 14, 5
  3. 3
    Rachel H. Westbrook, Geoffrey Dusheiko, Natural history of hepatitis C, Journal of Hepatology, 2014, 61, 1, S58

    CrossRef

  4. 4
    Pratima Sharma, Amy Hosmer, Henry Appelman, Barbara McKenna, Mohammad S. Jafri, Patricia Sullivan, Robert J. Fontana, Anna S. Lok, Immunological dysfunction during or after antiviral therapy for recurrent hepatitis C reduces graft survival, Hepatology International, 2013, 7, 4, 990

    CrossRef

  5. 5
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Liver Transplantation and Hepatitis C, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  6. 6
    Valentina Rosa Bertuzzo, Matteo Cescon, Maria Cristina Morelli, Paolo Di Gioia, Mariarosa Tamè, Stefania Lorenzini, Pietro Andreone, Giorgio Ercolani, Massimo Del Gaudio, Matteo Ravaioli, Alessandro Cucchetti, Alessandro Dazzi, Antonietta D’Errico-Grigioni, Antonio Daniele Pinna, Long-term antiviral treatment for recurrent hepatitis C after liver transplantation, Digestive and Liver Disease, 2012, 44, 10, 861

    CrossRef

  7. 7
    Fredric D. Gordon, Paul Kwo, Reem Ghalib, Jeffrey Crippin, Hugo E. Vargas, Kimberly A. Brown, Thomas Schiano, Eirum Chaudhri, Lisa D. Pedicone, Robert S. Brown, Peginterferon-α-2b and Ribavirin for Hepatitis C Recurrence Postorthotopic Liver Transplantation, Journal of Clinical Gastroenterology, 2012, 46, 8, 700

    CrossRef

  8. 8
    Shishir Shetty, David H Adams, Stefan G Hubscher, Post-transplant liver biopsy and the immune response: lessons for the clinician, Expert Review of Clinical Immunology, 2012, 8, 7, 645

    CrossRef

  9. 9
    Lydia M. Petrovic, Recurrent diseases following liver transplantation, Current Opinion in Organ Transplantation, 2012, 17, 3, 293

    CrossRef

  10. 10
    Marina Berenguer, Ramón Charco, Juan Manuel Pascasio, Jose Ignacio Herrero, Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation, Liver International, 2012, 32, 5
  11. 11
    Stefan G. Hübscher, Andrew D. Clouston, MacSween's Pathology of the Liver, 2012,

    CrossRef

  12. 12
    Maria Rendina, Stefano Fagiuoli, Patrizia Burra, Nicola Maurizio Castellaneta, Marianna Zappimbulso, Antonio Castellaneta, Roberto Bringiotti, Salvatore Fiabio Rizzi, Annamaria Squicciarino, Luigi Lupo, Alfredo Di Leo, Facing HCV recurrence after liver transplantation: antiviral therapy response and clinical outcome, Digestive and Liver Disease Supplements, 2011, 5, 1, 30

    CrossRef

  13. 13
    Nazia Selzner, Maha Guindi, Eberhard L. Renner, Marina Berenguer, Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients, Journal of Hepatology, 2011, 55, 1, 207

    CrossRef

  14. 14
    F.R. Ponziani, A. Gasbarrini, M. Pompili, P. Burra, S. Fagiuoli, Management of Hepatitis C Virus Infection Recurrence After Liver Transplantation: An Overview, Transplantation Proceedings, 2011, 43, 1, 291

    CrossRef

  15. 15
    Alpna R. Limaye, Roberto J. Firpi, Management of Recurrent Hepatitis C Infection after Liver Transplantation, Clinics in Liver Disease, 2011, 15, 4, 845

    CrossRef

  16. 16
    Natalie Bzowej, David R. Nelson, Norah A. Terrault, Gregory T. Everson, Lichen L. Teng, Avinash Prabhakar, Michael R. Charlton, PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus, Liver Transplantation, 2011, 17, 5
  17. 17
    Roger Klein Moreira, Recurrent Hepatitis C and Acute Allograft Rejection, Advances In Anatomic Pathology, 2011, 18, 5, 393

    CrossRef

  18. 18
    John O'Grady, The immunoreactive patient: Rejection and autoimmune disease, Liver Transplantation, 2011, 17, S3
  19. 19
    Romil Saxena, Swan N. Thung, Practical Hepatic Pathology: A Diagnostic Approach, 2011,

    CrossRef

  20. 20
    Paul J. Pockros, Fayez M. Hamzeh, Paul Martin, Ellen Lentz, Xiaolei Zhou, Sugantha Govindarajan, Anna S. Lok, Histologic outcomes in hepatitis C–infected patients with varying degrees of virologic response to interferon-based treatments, Hepatology, 2010, 52, 4
  21. 21
    Paul Martin, Hugo R. Rosen, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010,

    CrossRef

  22. 22
    K. Watt, B. Veldt, M. Charlton, A Practical Guide to the Management of HCV Infection Following Liver Transplantation, American Journal of Transplantation, 2009, 9, 8
  23. You have free access to this content23
    Marc G. Ghany, Doris B. Strader, David L. Thomas, Leonard B. Seeff, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, 2009, 49, 4
  24. 24
    Thomas Walter, Jean-Yves Scoazec, Olivier Guillaud, Valérie Hervieu, Philippe Chevallier, Olivier Boillot, Jérôme Dumortier, Long-term antiviral therapy for recurrent hepatitis C after liver transplantation in nonresponders: Biochemical, virological, and histological impact, Liver Transplantation, 2009, 15, 1
  25. 25
    Fredric D. Gordon, Paul Kwo, Hugo E. Vargas, Treatment of hepatitis C in liver transplant recipients, Liver Transplantation, 2009, 15, 2
  26. 26
    Gabriella Lengyel, Zsolt Tulassay, Treatment of recurrent hepatitis C virus infection in patients after liver transplantation, Clinical and Experimental Medical Journal, 2009, 3, 2, 237

    CrossRef

  27. 27
    Bijan Raziorrouh, Maria-Christina Jung, Carl Albrecht Schirren, Florian Loehe, Manfred Thiel, Hans Nitschko, Helmut Diepolder, Axel Ulsenheimer, Malte Heeg, Reinhart Zachoval, Norbert Hubert Gruener, Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12, European Journal of Gastroenterology & Hepatology, 2008, 20, 8, 778

    CrossRef

  28. 28
    Sandeep Mukherjee, Michael F. Sorrell, Controversies in Liver Transplantation for Hepatitis C, Gastroenterology, 2008, 134, 6, 1777

    CrossRef

  29. 29
    T. Reiberger, S. Rasoul-Rockenschaub, A. Rieger, P. Ferenci, A. Gangl, M. Peck-Radosavljevic, Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection, European Journal of Clinical Investigation, 2008, 38, 6
  30. 30
    Elizabeth C. Verna, Robert S. Brown, Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted, Clinics in Liver Disease, 2008, 12, 3, 637

    CrossRef

  31. 31
    Bruno Roche, Mylene Sebagh, Maria Laura Canfora, Teresa Antonini, Anne-Marie Roque-Afonso, Valerie Delvart, Faouzi Saliba, Jean-Charles Duclos-Vallee, Denis Castaing, Didier Samuel, Hepatitis C virus therapy in liver transplant recipients: Response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis, Liver Transplantation, 2008, 14, 12
  32. 32
    Alexander Kuo, Vivian Tan, Billy Lan, Mandana Khalili, Sandy Feng, John P. Roberts, Norah A. Terrault, Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection, Liver Transplantation, 2008, 14, 10
  33. 33
    Suzanne M Davison, Deirdre A Kelly, Management Strategies for Hepatitis C Virus Infection in Children, Pediatric Drugs, 2008, 10, 6, 357

    CrossRef

  34. 34
    E. Xirouchakis, C. Triantos, P. Manousou, A. Sigalas, V. Calvaruso, A. Corbani, G. Leandro, D. Patch, A. Burroughs, Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies, Journal of Viral Hepatitis, 2008, 15, 10
  35. 35
    George Mells, James Neuberger, Protocol Liver Allograft Biopsies, Transplantation, 2008, 85, 12, 1686

    CrossRef

  36. You have free access to this content36
    Sumihito Tamura, Yasuhiko Sugawara, Treatment strategy for hepatitis C after liver transplantation, Journal of Hepato-Biliary-Pancreatic Surgery, 2008, 15, 2
  37. 37
    Gabriella Lengyel, Zsolt Tulassay, A májtranszplantáció után visszatérő hepatitis C-vírus-fertőzés kezelése, Orvosi Hetilap, 2007, 148, 40, 1875

    CrossRef

  38. 38
    Nevin Yilmaz, Mitchell L. Shiffman, R. Todd Stravitz, Richard K. Sterling, Velimir A. Luketic, Arun J. Sanyal, A. Scott Mills, Melissa J. Contos, Adrian Coterell, Daniel Maluf, Marc P. Posner, Robert A. Fisher, A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation, Liver Transplantation, 2007, 13, 7
  39. 39
    Arno Kornberg, Bernadett Küpper, Andrea Tannapfel, Erik Bärthel, Katharina Thrum, Utz Settmacher, Antiviral maintenance treatment with interferon and ribavirin for recurrent hepatitis C after liver transplantation: Pilot study, Journal of Gastroenterology and Hepatology, 2007, 22, 12
  40. 40
    Alexander Kuo, Norah A. Terrault, Antiviral therapy in liver transplant recipients: Is SVR the only endpoint that matters?, Journal of Hepatology, 2007, 46, 3, 359

    CrossRef

  41. 41
    Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection, Journal of Gastroenterology and Hepatology, 2007, 22, 5
  42. 42
    Carmen M. Stanca, M Isabel Fiel, Nickolas Kontorinis, Kaushik Agarwal, Sukru Emre, Thomas D. Schiano, Chronic Ductopenic Rejection in Patients With Recurrent Hepatitis C Virus Treated With Pegylated Interferon Alfa-2a and Ribavirin, Transplantation, 2007, 84, 2, 180

    CrossRef

  43. 43
    T. Bizollon, P. Pradat, J.-Y. Mabrut, S. Radenne, C. Ducerf, J. Baulieux, J. C. Souquet, C. Trepo, Histological Benefit of Retreatment by Pegylated Interferon Alfa-2b and Ribavirin in Patients with Recurrent Hepatitis C Virus Infection Posttransplantation, American Journal of Transplantation, 2007, 7, 2
  44. 44
    Marina Berenguer, Management of Hepatitis C Virus in the Transplant Patient, Clinics in Liver Disease, 2007, 11, 2, 355

    CrossRef

  45. 45
    Roberts Brown, Jean C. Emond, Managing Access to Liver Transplantation: Implications for Gastroenterology Practice, Gastroenterology, 2007, 132, 3, 1152

    CrossRef

  46. 46
    T. Walter, J. Dumortier, O. Guillaud, V. Hervieu, P. Paliard, J.-Y. Scoazec, O. Boillot, Rejection Under Alpha Interferon Therapy in Liver Transplant Recipients, American Journal of Transplantation, 2007, 7, 1
  47. 47
    R. R. ARJAL, J. R. BURTON JR, F. VILLAMIL, H. R. ROSEN, Review article: the treatment of hepatitis C virus recurrence after liver transplantation, Alimentary Pharmacology & Therapeutics, 2007, 26, 2
  48. 48
    Hyung Joon Kim, Review: Clinical Outcome after Living Donor Liver Transplantation in Patients with Hepatitis C Virus-associated Cirrhosis, The Korean Journal of Hepatology, 2007, 13, 4, 489

    CrossRef

  49. 49
    John G. McHutchison, Michael P. Manns, Robert S. Brown, K. Rajender Reddy, Mitchell L. Shiffman, John B. Wong, Strategies for Managing Anemia in Hepatitis C Patients Undergoing Antiviral Therapy, The American Journal of Gastroenterology, 2007, 102, 4, 880

    CrossRef

  50. 50
    Pratima Sharma, Jorge A. Marrero, Robert J. Fontana, Joel K. Greenson, Hari Conjeevaram, Grace L. Su, Frederick Askari, Patricia Sullivan, Anna S. Lok, Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence, Liver Transplantation, 2007, 13, 8
  51. 51
    Francesco Paolo Picciotto, Giovanni Tritto, Alfonso Galeota Lanza, Luigi Addario, Massimo De Luca, GiovanGiuseppe Di Costanzo, Filippo Lampasi, Maria Teresa Tartaglione, Giuseppina Marino Marsilia, Fulvio Calise, Oreste Cuomo, Antonio Ascione, Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation, Journal of Hepatology, 2007, 46, 3, 459

    CrossRef

  52. 52
    Rosângela Teixeira, Érica Godinho Menezes, Thomas D. Schiano, Therapeutic management of recurrent hepatitis C after liver transplantation, Liver International, 2007, 27, 3
  53. 53
    Mitchell L. Shiffman, Treating chronic hepatitis C virus after liver transplantation: Balancing the risks against the chance for success, Liver Transplantation, 2007, 13, 8
  54. 54
    Douglas Meyer, Kirti Shetty, Treatment of recurrent hepatitis C following liver transplantation, Current Hepatitis Reports, 2007, 6, 2, 54

    CrossRef

  55. 55
    Marina Berenguer, Viral hepatitis after liver transplantation, Hepatology Research, 2007, 37,
  56. 56
    Thierry Vial, Jacques Descotes, Felix Braun, Matthias Behrend, 2007,

    CrossRef

  57. 57
    James R. Burton, Hugo R. Rosen, Acute rejection in HCV-infected liver transplant recipients: The great conundrum, Liver Transplantation, 2006, 12, S2
  58. 58
    Arno Kornberg, Bernadett Küpper, Andrea Tannapfel, Katharina Thrum, Erik Bärthel, Utz Settmacher, Antiviral treatment withdrawal in viremic HCV-positive liver transplant patients: impact on viral loads, allograft function and morphology, Liver International, 2006, 26, 7
  59. 59
    Bruno Roche, Didier Samuel, Aspects of hepatitis C virus infection relating to liver transplantation, European Journal of Gastroenterology & Hepatology, 2006, 18, 4, 313

    CrossRef

  60. 60
    M. Schmeding, A. Dankof, V. Krenn, M.G. Krukemeyer, M. Koch, A. Spinelli, J.M. Langrehr, U.P. Neumann, P. Neuhaus, C4d in Acute Rejection After Liver Transplantation—A Valuable Tool in Differential Diagnosis to Hepatitis C Recurrence, American Journal of Transplantation, 2006, 6, 3
  61. 61
    Lydia M. Petrovic, Early recurrence of hepatitis C virus infection after liver transplantation, Liver Transplantation, 2006, 12, S2
  62. 62
    Marina Berenguer, Antonio Palau, Alberto Fernandez, Salvador Benlloch, Victoria Aguilera, Martín Prieto, Jose-Miguel Rayón, Joaquín Berenguer, Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C, Liver Transplantation, 2006, 12, 7
  63. 63
    Tarik Asselah, Hamza Boudjema, Claire Francoz, Rodolphe Sobesky, Dominique Valla, Jacques Belghiti, Patrick Marcellin, François Durand, Hépatite C et transplantation hépatique, Gastroentérologie Clinique et Biologique, 2006, 30, 11, 1281

    CrossRef

  64. 64
    E. Oton, R. Barcena, J. M. Moreno-Planas, V. Cuervas-Mons, A. Moreno-Zamora, C. Barrios, S. Garcia-Garzon, A. Moreno, E. Boullosa-Graña, E. E. Rubio-Gonzalez, M. Garcia-Gonzalez, C. Blesa, M. L. Mateos, Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin, American Journal of Transplantation, 2006, 6, 10
  65. 65
    Elizabeth C. Verna, Robert S. Brown, Hepatitis C Virus and Liver Transplantation, Clinics in Liver Disease, 2006, 10, 4, 919

    CrossRef

  66. 66
    Marina Berenguer, Hepatitis C virus in liver transplantation: impact and treatment of hepatitis C virus recurrence, Current Opinion in Organ Transplantation, 2006, 11, 6, 599

    CrossRef

  67. You have free access to this content67
    Shigeru Marubashi, Keizo Dono, Atsushi Miyamoto, Yutaka Takeda, Hiroaki Nagano, Koji Umeshita, Morito Monden, Liver transplantation for hepatitis C, Journal of Hepato-Biliary-Pancreatic Surgery, 2006, 13, 5
  68. 68
    A. Kuo, N. A. Terrault, Management of Hepatitis C in Liver Transplant Recipients, American Journal of Transplantation, 2006, 6, 3
  69. 69
    Sakib K. Khalid, Jeffrey S. Crippin, Management of Hepatitis C in the Setting of Liver Transplantation, Clinics in Liver Disease, 2006, 10, 2, 321

    CrossRef

  70. 70
    Mandana Khalili, Andrew J Vardanian, Chris M Hamerski, Rou Wang, Peter Bacchetti, John P Roberts, Norah A Terrault, Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years, Clinical Transplantation, 2006, 20, 1
  71. 71
    Scott W. Biggins, Norah A. Terrault, Management of Recurrent Hepatitis C in Liver Transplant Recipients, Infectious Disease Clinics of North America, 2006, 20, 1, 155

    CrossRef

  72. 72
    Marina Berenguer, Manejo de la infección por el virus de la hepatitis C en el trasplante hepático, Gastroenterología y Hepatología, 2006, 29, 7, 422

    CrossRef

  73. 73
    M. Heydtmann, D. Freshwater, T. Dudley, V. Lai, S. Palmer, S. Hübscher, D. Mutimer, Pegylated Interferon Alpha-2b for Patients with HCV Recurrence and Graft Fibrosis Following Liver Transplantation, American Journal of Transplantation, 2006, 6, 4
  74. 74
    Nickolas Kontorinis, Kaushik Agarwal, Nassim Elhajj, M. Isabel Fiel, Thomas D. Schiano, Pegylated interferon–induced immune-mediated hepatitis post–liver transplantation, Liver Transplantation, 2006, 12, 5
  75. 75
    Yana Boyanova, Alcindo Pissaia, Filoména Conti, Olivier Soubrane, Yvon Calmus, Récidive virale C après transplantation hépatique: l’érythropoïétine permet le maintien du traitement antiviral, La Presse Médicale, 2006, 35, 2, 233

    CrossRef

  76. 76
    Paul Martin, Recurrent hepatitis C post–liver transplant: The lessons learned, Liver Transplantation, 2006, 12, 5
  77. 77
    Gary L. Davis, The challenge of progressive hepatitis C following liver transplantation, Liver Transplantation, 2006, 12, 1
  78. 78
    Jean-Michel Pawlotsky, Therapy of hepatitis C: From empiricism to eradication, Hepatology, 2006, 43, S1
  79. 79
    M. Berenguer, Tratamiento de la hepatitis C antes y después del trasplante hepático, Gastroenterología y Hepatología, 2006, 29, 190

    CrossRef

  80. 80
    James R. Burton, Hugo R. Rosen, Treatment of HCV recurrence: Do the pretransplantation rules apply?, Liver Transplantation, 2006, 12, 7
  81. 81
    Marina Berenguer, Hepatitis C after liver transplantation: risk factors, outcomes, and treatment, Current Opinion in Organ Transplantation, 2005, 10, 2, 81

    CrossRef

  82. 82
    Robert S. Brown, Hepatitis C and liver transplantation, Nature, 2005, 436, 7053, 973

    CrossRef

  83. 83
    Isabelle Morard, Francesco Negro, How should we treat recurrent hepatitis C after liver transplantation?, Journal of Hepatology, 2005, 42, 4, 462

    CrossRef

  84. 84
    Christos Triantos, Dimitrios Samonakis, Rosa Stigliano, Ulrich Thalheimer, David Patch, Andrew Burroughs, Liver Transplantation and Hepatitis C Virus: Systematic Review of Antiviral Therapy, Transplantation, 2005, 79, 3, 261

    CrossRef

  85. 85
    Robert G. Gish, Nezam H. Afdhal, Douglas T. Dieterich, K. Rajender Reddy, Management of hepatitis C virus in special populations: Patient and treatment considerations, Clinical Gastroenterology and Hepatology, 2005, 3, 4, 311

    CrossRef

  86. 86
    Naga Chalasani, Cosme Manzarbeitia, Peter Ferenci, Wolfgang Vogel, Robert J. Fontana, Michael Voigt, Caroline Riely, Paul Martin, Lewis Teperman, James Jiao, Juan Carlos Lopez-Talavera, Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials, Hepatology, 2005, 41, 2
  87. 87
    J.M. Moreno Planas, E. Rubio Gonzalez, E. Boullosa Graña, A. Garrido Botella, C. Barrios Peinado, J.L. Lucena Poza, M. Jiménez Garrido, V. Sanchez Turrion, V. Cuervas-Mons Martinez, Peginterferon and Ribavirin in Patients With HCV Cirrhosis After Liver Transplantation, Transplantation Proceedings, 2005, 37, 5, 2207

    CrossRef

  88. 88
    E. Oton, R. Barcena, S. Garcia-Garzon, A. Moreno-Zamora, A. Moreno, M. Garcia-Gonzalez, C. Blesa, J.R. Foruny, P. Ruiz, Pegylated Interferon and Ribavirin for the Recurrence of Chronic Hepatitis C Genotype 1 in Transplant Patients, Transplantation Proceedings, 2005, 37, 9, 3963

    CrossRef

  89. 89
    Marina Berenguer, Treatment of Hepatitis C after Liver Transplantation, Clinics in Liver Disease, 2005, 9, 4, 579

    CrossRef

  90. 90
    Scott W. Biggins, Norah A. Terrault, Treatment of Recurrent Hepatitis C After Liver Transplantation, Clinics in Liver Disease, 2005, 9, 3, 505

    CrossRef

  91. 91
    Bradley T. Kovach, Thomas Stasko, Use of topical immunomodulators in organ transplant recipients, Dermatologic Therapy, 2005, 18, 1
  92. 92
    Guy W. Neff, Christopher B. O'Brien, Jose Nery, Norah J. Shire, Seigo Nishida, Julia delaGarza, Marzia Montalbano, Kamran Safdar, Phillip Ruiz, Eric Rideman, Jose A. Gascon, Andreas G. Tzakis, Juan Madariaga, Steven M. Rudich, Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection, Liver Transplantation, 2004, 10, 12
  93. 93
    Mark W. Russo, Roshan Shrestha, Is severe recurrent hepatitis C more common after adult living donor liver transplantation?, Hepatology, 2004, 40, 3
  94. 94
    James R. Burton, Hugo R. Rosen, Retransplantation for hepatitis C: What do we really know?, Liver Transplantation, 2004, 10, 12
  95. 95
    Matthew H. Levine, Sandy Feng, Clinical Allograft Rejection Syndromes in Liver Transplantation,
  96. 96
    Ed Gane, Liver Transplantation for Chronic Hepatitis B and C,
  97. 97
    Kiran Bambha, Norah A. Terrault, Long-Term Management of Recurrent Primary Liver Disease,
  98. 98
    Ed Gane, Prevention and Treatment of Recurrent HBV and HCV Infection,
  99. 99
    Kymberly D. S. Watt, Marie A. Laryea, Recurrent Disease Following Liver Transplantation,
  100. 100
    Ed Gane, Treatment of Recurrent Hepatitis C Following Liver Transplantation,